Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 causes gastrointestinal disease with the potential for life-threatening sequelae. Although Shiga-like toxins are responsible for much of the serious pathology in humans, the bacterium also possesses a type III protein secretion system that is responsible for intimate attachment to host intestinal mucosa. This sophisticated interaction requires co-ordination that is governed by environmental and genetic factors. Ongoing research supports the following model for how EHEC enables and controls this process: (i) specific environmental cues that are present in the host result in the expression of a number of adhesins, including fimbriae, which allow the initial binding to the mucosal surface. The same conditions support the expression of the basal type III secretion apparatus; (ii) targeting and assembly of the translocon requires both an mRNA signal and chaperones, with coupled translation and secretion of translocon proteins, EspA, B and D; (iii) opening up of a conduit between the bacterium and host cell releases a cytoplasmic pool of effector proteins. A consequence of this is increased expression of particular effector proteins. Potentially, different proteins could be released into the cell at different times or have activities modulated with time; (iv) intimate contact between the translocated intimin receptor (Tir) and the bacterial surface factor intimin requires translocon expression to be down-regulated and translocon filaments to be lost. Fluorescent protein fusions allow contact-mediated regulation and protein targeting through the type III secretion system to be studied in detail.
Introduction
The area of cellular microbiology has flourished in the last 10 years and has provided a glimpse of the complex interactions that many bacteria have with eukaryotic cells. One front-line of this research is the battle between Gramnegative enteric bacteria and certain host cells, such as macrophages and epithelial cells. Many of the interactions involve signalling pathways within the host cell that can be induced or modulated deliberately by the bacterium to gain an advantage. One level of this deliberate induction is the binding of bacterial factors to an external eukaryotic receptor to instigate a response in the host cell, for example bacterial uptake triggered by ligand binding. In a more complex way, bacteria are able to interfere with normal signalling by injecting specific effector proteins into host cells. The main mechanism that has been identified for the transfer of such effectors into host cells is type III secretion. Type III secretion systems have been recognized in many bacterial pathogens and the effector proteins have varied activities that depend on the bacterium involved [1] [2] [3] [4] [5] [6] . For example, Yersinia spp. are able to inject proteins into macrophages to physically disable Key words: gastrointestinal disease, protein targeting, type III secretion.
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the macrophage and prevent phagocytosis of the bacterium while other proteins silence the macrophage and prevent release of 'call for help' cytokines, with the final blow being the induction of apoptosis in the macrophage [7, 8] . In enterohaemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC respectively), proteins with various functions are released that promote and probably help sustain a unique interaction with the host cell. The present paper is a review of the type III secretion system in EHEC, focusing on aspects of gene regulation, organelle structure, targeting of secreted proteins and cellular functions of effectors.
EHEC and type III secretion
The majority of EHEC infections of humans originate from ruminants, which are considered the natural host for these bacteria [9] [10] [11] [12] [13] . The primary function of the type III secretion system in cattle is persistence in the very terminal portion of the bovine gastrointestinal tract [14] . Most of the time, this appears as an inert interaction although this may be the consequence of the interplay between secreted proteins and the host cell, which leads to the suppression of pro-inflammatory pathways. In humans, this similar interaction appears to have a very different consequence and, coupled to the destructive effects of Shiga-like toxins, leads to damage of the intestinal mucosa and development of haemorrhagic colitis [15] . The genes for the EHEC and EPEC type III secretion apparatus, and certain secreted proteins, are present on the locus of enterocyte effacement (LEE) [16] [17] [18] [19] . This pathogenicity island is commonly inserted within the selC tRNA locus in EHEC and EPEC [20] . Interestingly, the cloned 36 kb region from EPEC is able to confer attaching and effacing (A/E) lesions on E. coli K-12, but this is not the case for the LEE region that is cloned from EHEC O157 [16, 21] . Although the present review is focused on EHEC O157, it does draw upon a large body of literature about EPEC. It is clear that the LEE regions between EHEC and EPEC are regulated differently and there may be functional differences to the proteins that are secreted. EHEC O157 is considered to have evolved from an EPEC O55 strain [22] and the intervening period has seen considerable changes in effector-protein sequences and, presumably, in how these are controlled.
The LEE contains over 40 open reading frames (ORFs) in at least five operons, with the first three operons being virtually identical between EHEC O157 and EPEC O127 [19] . LEE1, 2 and 3 contain 22 ORFs and primarily encode products that are required for the basal type III secretion apparatus that spans the two membranes [18, 23, 24] . A fourth operon (LEE4) encodes EscF and the secreted proteins EspA, B, D and F (where 'Esp' denotes E. coli secreted protein). These enable a translocon and pore to be formed, which allows effector protein transfer into the host cell [25] [26] [27] [28] [29] [30] [31] [32] . A further operon contains the translocated intimin receptor (Tir), its chaperone (CesT) and intimin [33] [34] [35] . Other smaller operons and individual ORFs are also present, including one that encodes the mitochondria-associated protein, MAP (ORF19) [36] . The main pathological response that is detected following protein secretion is the intimate attachment of the bacterium to the eukaryotic cell, which requires the rearrangement of the host cell cytoskeleton leading to the formation of A/E lesions. The bacterium injects its own receptor, Tir, which binds to intimin on the bacterial surface, and a considerable amount is now known about this interaction [16, 35, [37] [38] [39] [40] . This in turn triggers actin rearrangement in the cell. In the end, the bacterium appears tightly cupped by the host cell, almost embedded [27, 41] . How this association actually benefits the bacterium is unclear. This embedded state may promote persistence and/or allow access to cellular nutrients. To promote persistence, other effects on epithelial cell turnover and inflammatory responses could be envisaged and this may be the role of the growing list of proteins that are targeted into the cell. The translocon apparatus is initially an extended structure primarily made up of EspA [27, 42] . This protruding organelle may be needed to bypass microvilli or mucus layers. However, in order for intimate attachment to then occur, these structures would need to be shortened or lost and there is some evidence to support this [27] . Once attached, EPEC are able to recruit other bacteria via a latticework of bundle-forming pili and flagellae, leading to the formation of micro-colonies [43] [44] [45] . Certain EHEC strains also form micro-colonies with more efficiency than others, indicating the presence of functionally equivalent structures.
When to secrete
Levels of type III protein secretion are strain-and mediumdependent. Certain media, such as Hepes-buffered minimal essential medium, promote the secretion of EspA, B and D, and Tir. This is true for several EPEC strains and most humandisease-associated EHEC O157. However, the majority of bovine-origin verotoxigenic E. coli O157 strains secrete relatively little Esp proteins into this medium, but are able to form A/E lesions on contact with HeLa cells [46] . Media conditions that appear to stimulate secretion are those considered to mimic the gastrointestinal tract [47] . Recently, the addition of bicarbonate ions to Luria broth has been shown to stimulate secretion [48] . Such triggers are important because they simplify in vitro experiments, as has proved invaluable with the stimulation of type III secretion in Yersinia spp. by low calcium levels. Genetic factors include the lee-encoded regulator that has homology with the histone-like nucleoid-structuring protein (H-NS) and activates LEE1, 2 and 3 expression by relieving H-NS repression [49, 50] . LEE1 itself is expressed at much higher levels in late exponential phase and this has been shown to be due to the increased population density and quorum sensing [51] . Another density sensor, SdiA, actually shuts off LEE4 secretion in response to another soluble factor [52] . The importance of these systems in vivo are not yet clear.
Another key signal appears to be cell contact, even for those strains that already secrete proteins into the tissue culture supernatant [30, 53, 54] . This is confirmed by our own studies which demonstrate LEE1, 3 and tir induction on contact with HeLa cells. In Yersinia enterolitica, secreted protein expression is repressed by LcrQ activity. Upon cell contact, a plug-blocking secretion, YopN, is removed to allow the release of secreted proteins into the host cell. One of the released proteins is LcrQ and, as its level in the bacterial cell falls, repression of effector protein expression is lifted. It is this process that can be initiated by reducing calcium levels in the medium [3] . To date, no homologues for YopN and LcrQ have been found in EPEC or EHEC, so a different mechanism of contact-mediated expression is probable [3] . The plant pathogen Ralstonia solanacearum has hrp genes that are induced upon cell contact. This induction requires prhA, which is homologous with three compartment iron-sensing and transducing systems in other bacteria [55] . This outermembrane protein may act to signal contact with a host cell receptor and up-regulate gene expression by phosphorylation pathways, or other mechanisms, to induce structural change in a transcriptional activator. Homologues of prhA are present in E. coli O157 but their roles are unknown. The differences in affinities that such regulators may have for key promoters would provide a way to govern the timing of secreted protein expression and release.
Another way to regulate temporally is to have high levels of 'early' stage proteins present in the bacterial cell ready for release and have 'late' stage proteins that require induction. MAP appears to enter cells very early in the infection process [56] , and our results indicate that the map promoter is expressed at relatively high levels even before contact and this level does not appear to increase. In contrast, tir promoter activity is only just detectable before contact but is expressed at higher levels after contact. As discussed below, MAP appears to have at least two functions: one at mitochondria and one independent of this localization [56] . Filopodia formation at an early stage of lesion formation is promoted by MAP and then followed by pedestal formation. Pedestal formation is actually inhibited by MAP, so it would be logical to have MAP active in its non-mitochondrial role early and then increase Tir levels to bring about actin rearrangements after intimate contact is made. Very little is known about the trafficking or timing of release of other proteins, such as EspF, and the complexity of the situation will increase as other translocated proteins are identified.
The longer-term dynamics of lesion formation are unknown as, once bacterial numbers reach certain levels in cell-culture assays, or large micro-colonies form on cells, the eukaryotic cells die. Presumably, as long as the host cell remains healthy, a proportion of the bacteria will remain attached. It seems that intimately attached bacteria divide on the cell since small chains of bacteria can be imaged on the eukaryotic cell surface. Once a host cell undergoes apoptosis or necrosis then bacteria may sense this and release themselves. To some extent, the intimate-attachment mechanism itself requires a healthy cell and perhaps this interaction ceases once protein phosphorylation or other modification events stop within the host cell.
Mechanics of secretion
Much of what is known about the basic structure of the type III secretion apparatus is based on association with extensive research carried out on the flagellal assembly apparatus and then by further extrapolation from Yersinia type III assembly homologues to EPEC and EHEC [3] . The purification of parts of the membrane-associated apparatus from Salmonella, Shigella and EPEC has allowed some visualization of the overall structure and an assessment of the components [57] [58] [59] . The organelle is principally a basal apparatus that spans the inner and outer membranes and a short projecting needle. The structure is illustrated in Figure 1 , with an indication of some of the proteins involved. Although many are required for the physical structure of the apparatus, others are likely to be involved in targeting and driving secretion of the outer-membrane apparatus proteins and then secreted proteins. EscD, EscR, EscU, EscV, and potentially EscS and EscT, probably span the inner membrane and associate with a putative cytoplasmic ATPase EscN that is required for secretion of proteins. Yeast two and three-hybrid systems have been used in Yersinia to demonstrate which proteins interact directly [60] . EscC is likely to be the main protein ring in the outer membrane onto which a needle composed of EscF is connected [42, 61] . This in turn directly connects to the translocon syringe of EspA. In turn, physical interaction has been demonstrated between EspA and EspB, and between EspB and EspD [31, 62, 63] . EspB and EspD form pores of 3-5 nm in diameter in the host cell membrane [31] , presumably through which translocated proteins pass via the basal apparatus, needle and EspA filament.
Signals for secretion
The signals that govern the export of proteins by the type III secretion apparatus have been researched very thoroughly over the past decade and have caused much debate. Whereas the majority of EHEC LEE-encoded apparatus proteins have homologues in Yersinia, the effector proteins are distinct, with only EspB showing some homology with YopB of Yersinia. The majority of the work in this area has focused around the 14 known Yop effector proteins [64] , allowing detailed studies of potential common secretion signals. Comparison of these proteins does not reveal any obvious secretion signal at the amino acid level and no physical similarity, such as hydrophobicity, exists between the substrates [65] . Similarly, in EHEC and EPEC, EspA, B and D all lack classical N-terminal signal sequences [66] . This lack of similarity distinguishes type III secretion from other export pathways that utilize substrates with clearly defined secretion signals.
In order to understand type III secretion signals, two techniques have been employed extensively: hybrid fusion and mutagenesis of secreted proteins. Hybrid proteins that consist of portions of secretion substrates fused to reporters such as calmodulin-dependent adenylate cyclase (Cya) and neomycin phosphotransferase (Npt) have been used to determine the minimum signal required for secretion. In a similar way, we have used fusions to β-lactamase to try to understand the secretion signals of EHEC secreted proteins. The fusion approach was first used to demonstrate that the first 15 residues of YopE were required for export of Cya [65, 67] . Further studies showed that only the first 11 amino acids of YopE are necessary to allow export of the hybrid fusion across the bacterial membrane [68] and the importance of the first 7 amino acids for export of the wild-type protein was demonstrated by mutational analysis [68] . However, work by Anderson and Schneewind [69] using scanning mutagenesis of the secretion signal, including creating frameshifts in YopE, suggested rather than the N-terminal secretion signal directing export, that the yop mRNAs serve to direct secretion. Multiple synonymous mutations that change the mRNA sequence of codons 1-12 for YopE without altering the signal peptide did not affect secretion. These data indicate that yopE mRNA is not the signal for type III transport [70] . However, similar studies carried out on yopQ, in which mRNA mutants were generated, suggest that, in the case of this substrate, mRNA structure controls initiation of translation of the YopQ polypeptide into the type III pathway [71] .
Chaperones also have an important role in directing type III secreted proteins from the bacterial cell. In EPEC, CesD [72] and CesT [33, 73] are critical for EspD and Tir secretion respectively. These Ces chaperones have direct homologues in Yersinia, such as SycD (CesD) and SycH (CesT). The best studied Yersinia chaperone is SycE, which aids YopE secretion. This particular chaperone has no direct EPEC or EHEC homologue. The chaperone-based type III secretion signal is located between residues 15 and 100 of YopE. This signal is only recognized by the type III apparatus when YopE is bound to SysE [74] .
Figure 1 Model of LEE4 expression and Esp protein secretion in EHEC O157
(1) Transcription of LEE4 occurs from a promoter in front of sepL which produces a 5.6 kb mRNA containing espADB. (2) This is immediately processed to produce at least three mRNA species including a 1.2 kb transcript that encodes sepL and a 2.8 kb transcript that encodes espADB. (3) Processing of the 2.8 kb transcript is a key step in determining whether or not secretion occurs. (3a) Under appropriate environmental conditions, such as growth in Hepes-buffered minimal essential medium for high secretors or cell contact for low secretors, the transcript is translated at the type III secretion apparatus (TTSS). (3b) When secretion is not triggered, for example low secretors grown in Hepes-buffered minimal essential medium, the mRNA is still produced, but is not efficiently translated at the TTSS. It is proposed that a pool of this mRNA is present in the cell and allows immediate secretion of EspA, B and D under the right conditions, such as cell contact. (4) The mRNA may either associate directly with the TTSS (4a) or be trafficked to the TTSS via a chaperone (4b). (5) The final step is the coupled translation and secretion of the Esps at the TTSS. The effective export of at least EspD requires a chaperone, CesD [72] , also located in the membrane, presumably within the apparatus.
Work in Salmonella has suggested that both mRNA and peptide signals could be used in type III systems and that both signals are not mutually exclusive [75] . A unified model in which chaperones participate in the coupling of translation to secretion using both signals would certainly explain much of the difficulty in clearly disseminating the exact nature of the type III secretion signal. If translation and secretion are intimately coupled then it is clear that mRNA localization to the type III apparatus would have to occur in order to allow in situ translation of the target substrate. This localization would require signals within the mRNA molecule, but would also require signals within the polypeptide that ensure correct interaction with its cognate chaperone for efficient secretion through the apparatus. Our own studies with EspD in EHEC have indicated that mRNA signals are present, 5 of the coding region, which play a role in localization of the mRNA to the cell membrane. This indicates that coupled translation-secretion occurs in EHEC. Our future work aims to clarify the secretion signals required for type III export in EHEC. Techniques such as localization of specific mRNAs within the host cell and tagging of target substrates by fluorescent markers will be used to gain a better understanding of the secretion process.
Secreted effector proteins
The effector proteins Tir [35] , EspF [76] and MAP [36] are capable of subverting multiple cellular processes, including cytoskeletal rearrangements, apoptosis and cytokine release. Tir orchestrates pedestal formation, serving as a nucleator of actin re-polymerization and directing the recruitment of several cytoskeletal proteins to the site of EHEC attachment. These include α-actinin, ezrin, cortactin (via EspB in EHEC), talin, fimbrin, vasodilator-stimulated phosphoprotein (VASP), neural Wiskott-Aldrich syndrome protein (N-WASP) and actin-related protein (Arp)2/3 complex [77] [78] [79] . Recruitment in EHEC is independent of Tir tyrosine phosphorylation yet the composition of the pedestal is similar to EPEC, with the exception of the adaptor proteins, growth-factor-receptor-bound protein 2 (Grb2) and CrkII. Grb2 is an activator of N-WASP and the Arp2/3 complex [80] , both of which are essential for pedestal formation in EPEC [81] and hence may be involved in the recruitment of these proteins, a process driven by tyrosine phosphorylation of Tir. It is tempting to speculate that serine/threonine phosphorylation of Tir [82] may result in EHEC delivering its own adaptor proteins to cells to initiate pedestal formation or that phosphorylation of Tir is not essential for this process.
Temporal regulation in the host cell by effector molecules is evident in the roles enacted by Tir and MAP in filopodia formation, an early and transient event in lesion formation. Like Tir, MAP is multi-functional, inducing the formation of filopodia via the Rho GTPase cdc42, a mechanism that is dissociated from its targeting to the mitochondria. MAP-induced signalling inhibits pedestal formation; conversely, Tir, in association with intimin, down-regulates filopodia, consistent with the possession of a GTPase-activating protein (GAP)-like activity. Hence the pathogen uses strategies to delay the function of effector molecules, Tir and MAP, facilitating the temporal and co-ordinate regulation of host cell signalling in A/E lesion formation [56] .
EspF is part of a proposed 'two hit' hypothesis by which EPEC induces death in host cells with features characteristic of both apoptosis and necrosis. EspF induces epithelial cell apoptosis, a proline-rich structure suggesting it may bind to Src homology 3 (SH3) or enabled/VASP homology 1 (EVH1) domains of host-cell signalling molecules, such as the tyrosine kinases Src and Fyn, phospholipase C-γ (activated in response to EPEC [40] ) and N-WASP, the latter being localized in the vicinity of condensed actin after EPEC infection [81] .
In order to understand the mechanism of EHEC/EPEC diarrhoea, it is likely that further secreted proteins that are required for the initiation of signalling events in host cells will need to be identified. Comparisons between EHEC and EPEC will continue to be useful. Recent research showed that EHEC induces a pro-inflammatory response in vitro by promoting release of the chemokine interleukin (IL) 8 through the activation of MAP kinase, activator protein-1 (AP-1) and nuclear factor κB signalling pathways [83] . Secreted proteins may modulate this cytokine response, although this has not been demonstrated. Another key factor that separates EPEC and EHEC that has not been discussed is the production of Shiga-like toxin. In humans, Shiga-like toxin superinduces IL8 and is therefore pro-inflammatory [84, 85] . However, in cattle, the primary host, our data indicate a suppressive role for Shiga-like toxin, although whether or not this occurs during colonization is currently being investigated.
The way forward
The type III secretion system of EHEC probably has its main role in promoting persistence within the ruminant host. Secreted proteins drive the intimate association of the bacterium with the host epithelial cell. This should lead to a pro-inflammatory response to remove the organism, as occurs in humans. However, in cattle, such a response has not been observed, indicating that the organism is able to suppress this reaction. It may be that certain secreted proteins, in concert with Shiga-like toxins, fulfil this function. Regulation of the process is complex and reflects when the system is required and the need to restrict export to effector proteins. Interference with the regulation and activity of the system and its effectors may provide novel treatments, as well as a way to reduce carriage of EHEC in the ruminant host.
